Drug-Induced Hypothermia Shows Promise for Treating Stroke and Cardiac Arrest Patients

Scientists are exploring the use of everyday medications to induce hypothermia, a state of rapid body cooling, which could significantly improve outcomes for patients suffering from strokes, cardiac arrests, and spinal cord injuries. The goal is to administer these drugs at the scene of an emergency, a crucial step during the "golden hour" when prompt treatment can prevent long-term disability and death.

Therapeutic hypothermia, which involves lowering body temperature to between 33-34 degrees Celsius for a period, is already established for treating conditions like traumatic brain injuries, spinal cord injuries, and oxygen deprivation in newborns. This process slows the brain's metabolic rate, reduces inflammation, and prevents brain cell death, thereby increasing the chances of recovery.

Challenges with Current Methods

Existing methods for inducing hypothermia, such as applying cooling bags to the skin or infusing cold saline, can only be performed in a hospital setting. This delay can be critical, especially for stroke patients who need immediate intervention to minimize damage. Current techniques also have drawbacks, including potential spikes in stress hormones, slowed heart rate, low blood pressure, and an increased risk of infection due to changes in white blood cells and impaired blood clotting.

A New Approach with Medications

A study conducted by researchers at Capital Medical University in Beijing investigated the combined effects of chlorpromazine (used for schizophrenia and nausea) and promethazine (used for allergies and nausea). In mice and primates, this combination effectively lowered body temperature and reduced brain damage following stroke. However, a subsequent clinical trial with 32 human stroke patients showed only a minor temperature drop of around 1 degree Celsius, which was insufficient to induce therapeutic hypothermia.

Scientists theorize that humans' lower surface area-to-body mass ratio might hinder heat dissipation, making it harder to achieve significant cooling with these drugs compared to smaller mammals. Another hypothesis suggests that these drugs might act on the brain's thermostat, preventing shivering – the body's natural mechanism to generate heat. Unlike physical cooling methods, drug-induced hypothermia could potentially bypass these resistance mechanisms and also widen blood vessels to release heat and reduce metabolic rate.

Exploring Household Medicines

Researchers are also examining whether common over-the-counter medications like paracetamol, aspirin, and ibuprofen could be used for rapid cooling. Studies have shown that paracetamol can lower body temperature by up to 1 degree Celsius for several hours by blocking the COX-1 enzyme, which is involved in raising body temperature. Samir Ayoub, a senior lecturer in pharmacology at the University of East London, believes that a combination of drugs might be necessary to achieve the required cooling effect without resorting to dangerously high doses of a single medication, which could lead to toxicity, such as liver damage from paracetamol.

Despite the promising potential, some experts remain cautious. Professor Malcolm Macleod of the University of Edinburgh noted that the temperature reduction observed in the human trial was too small to be clinically effective, suggesting that significant hurdles remain before this approach can be widely adopted. Further research is needed to optimize drug combinations and dosages to safely and effectively induce hypothermia in critical care situations outside of a hospital environment.